In August 2010, the FDA alerted the public about issues regarding Lamictal based on reports submitted since December 1994 (the time the drug was approved) through November 2009. That report revealed around 40 cases of Aseptic Meningitis in both pediatric and adult patients taking Lamictal. Out of those 40 patients, 35 of them required hospitalization.
Symptoms of Meningitis include headache, stiff neck, nausea, rash, sensitivity to light and vomiting. In cases of Aseptic Meningitis, it is crucial to diagnose the underlying cause as quickly as possible so cessation of drugs and treatment can be hastily initiated. The FDA has advised that any patient taking Lamictal contact their healthcare provider if they experience any of these symptoms.